The ROE (Return on Equity) of Harbin Pharmaceutical Group Co Ltd (600664.SS) is 11.75%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 11.75% |
| 2023-12-31 | 8.37% |
| 2022-12-31 | 10.72% |
| 2021-12-31 | 9.65% |
| 2020-12-31 | -30.98% |
| 2019-12-31 | 1.03% |
| 2018-12-31 | 5.90% |
| 2017-12-31 | 5.77% |
| 2016-12-31 | 10.04% |
| 2015-12-31 | 8.22% |